[1]
J. L. Carrasco, E. Álvarez, J. M. Olivares, and J. Rejas, “A comparative cost-analysis of initiating pregabalin or SSRI/SNRI therapy in benzodiazepine-resistant patients with generalized anxiety disorder in Spain”, Actas Esp Psiquiatr, vol. 41, no. 3, pp. 164–174, May 2013.